Filter
2214
Filtered Results: 2214
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
247
New Publications
715
Language
Document type
No document type
1353
Guidelines
321
Studies & Reports
270
Manuals
116
Strategic & Response Plan
98
Training Material
23
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
156
Kenya
77
South Africa
63
Global
62
Nigeria
59
Uganda
54
Nepal
48
Sierra Leone
45
Western and Central Europe
44
Tanzania
43
Ghana
40
Zambia
38
Ethiopia
37
Myanmar / Burma
37
Malawi
35
Bangladesh
31
Liberia
31
Africa
29
Namibia
27
Lesotho
19
Eastern Europe
19
South–East Asia Region
18
Rwanda
16
Zimbabwe
16
Cambodia
15
Asia
14
Latin America and the Carribbean
13
Botswana
13
Ukraine
12
Syria
12
Philippines
12
Congo, Democratic Republic of
10
Indonesia
10
Russia
8
Tajikistan
7
Cameroon
7
South Sudan
7
Eswatini/ Swaziland
7
Albania
6
Senegal
6
West and Central Africa
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
East and Southern Africa
6
Pakistan
6
Thailand
5
Burkina Faso
5
Middle East and North Africa
5
Laos
4
Guinea
4
Mozambique
4
Afghanistan
3
Germany
3
Sudan
3
Georgia
3
Iraq
3
Benin
2
China
2
Kyrgyzstan
2
USA
2
Haiti
2
United Kingdom
2
Brazil
2
Sri Lanka
2
Bhutan
2
Somalia
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Singapore
1
Uzbekistan
1
Peru
1
Qatar
1
Bulgaria
1
Lithuania
1
Jordan
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Southern Africa
1
Lebanon
1
Vietnam
1
Moldova
1
Yemen
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
915
Clinical Guidelines
235
Public Health
142
Women & Child Health
105
Key Resources
73
Pharmacy & Technologies
41
Capacity Building
36
Toolboxes
HIV
254
TB
190
AMR
146
Mental Health
131
COVID-19
76
Pharmacy
75
Caregiver
51
NTDs
51
Rapid Response
48
NCDs
44
Ebola
38
Planetary Health
33
Conflict
28
Global Health Education
28
Disability
24
Refugee
22
Natural Hazards
10
Polio
10
Cholera
9
Health Financing Toolbox
9
Specific Hazards
8
Zika
5
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
Alcohol use is deeply embedded in the social landscape of many societies, and some 2300 million people drink alcoholic beverages in most parts of the world. At the same time, more than half of the global population aged 15 years and older reported having abstained from drinking alcohol during the pr...
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i...
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Providing quality, stigma-free services is essential to equitable health care for all and achieving global HIV goals and broader Sustainable Development Goals related to health. Every person has the right to the highest attainable standard of physical and mental health. Countries have a legal obliga...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and ...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
760 WEEKLY EPIDEMIOLOGICAL RECORD, NOS. 51/52, 20 DECEMBER 2024, pp.760-769. In French and English
On 17 October 2017, the Ugandan Ministry of Health notified WHO of a confirmed Marburg outbreak of Marburg Virus disease (MVD) in Kween district, Eastern Uganda. The outbreak was officially declared by the Ministry of health on 19 October 2017.
As of 7 November, four cases of MVD have been reported...
